Elucid Bioimaging, Inc. announced that the US Centers for Medicare & Medicaid Services will double reimbursement for cardiac computed tomography angiography (CCTA) from $175 to $357.13, effective January 1, 2025. This change, resulting from six years of advocacy, aims to enhance access to CCTA, particularly in non-urban areas, and reflects its growing importance in cardiac care. The increase aligns with recent coverage decisions for AI-enabled plaque analysis, potentially improving early identification of high-risk cardiovascular conditions.
MedAxiom has partnered with Shockwave Medical to promote the benefits of intravascular lithotripsy (IVL) technology, which effectively breaks up severely calcified plaques in arteries. Acquired by Johnson & Johnson MedTech, Shockwave's IVL has received FDA approval for treating both peripheral arterial disease and coronary artery disease, showing significant improvements in PCI outcomes. MedAxiom, a consulting firm focused on cardiology, aims to navigate the complexities of the healthcare environment for heart teams.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
